Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents

by Subhasish Tapadar, Shaghayegh Fathi, Bocheng Wu, Carrie Q. Sun, Idris Raji, Samuel G. Moore, Rebecca S. Arnold, David A. Gaul, John A. Petros, Adegboyega K. Oyelere
Published 2020-10-01